ORG Wealth Partners
INBX icon

ORG Wealth Partners’s Inhibrx INBX Stock Holding History

ORG Wealth Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$100 Buy
+1
New +$100 ﹤0.01% 2453

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

ORG Wealth Partners's INBX Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Inhibrx (INBX) in Q3 2026: 1 share worth $100. The stake represents ﹤0.01% of the portfolio and ranks #2453 among its holdings.

70 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • ORG Wealth Partners held 1 share of Inhibrx worth $100 as of Q3 2026.
  • Inhibrx was a new ORG Wealth Partners position in Q3 2026.
  • Inhibrx made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2453 holding.
  • 70 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.